Recruiting
Phase 2

A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation

Sponsor:

Inmune Bio, Inc.

Code:

NCT05318976

Conditions

Alzheimer Disease

Dementia

Brain Diseases

Central Nervous System Diseases

Nervous System Diseases

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

XPro1595

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information